Indian on-line pharmacy startup PharmEasy, as soon as valued at $5.6 billion, continues to be about 92% beneath its peak valuation, based on estimates by its investor Janus Henderson. In line with the British-American international asset agency, which disclosed the way it values its shares within the Indian startup in a securities submitting, PharmEasy’s implied valuation on the finish of […]
© 2024 TechCrunch. All rights reserved. For private use solely.